Delivery Order SPE2DB22D2006-SPE2DB25FW2QS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits valued at $2,297.31 with a firm fixed price structure. The contract, issued on August 12, 2025, with completion targeted for August 13, 2025, represents a single delivery of emergency medical supplies to support military and federal healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.20 to AmerisourceBergen Drug Corp for Glucosan 1 mg Emergency Kits, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the procurement of Glucagon 1 mg Emergency Kits, valued at $2,428.73 with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by July 31, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.87 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,163.09 to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of July 30, 2025. This contract utilizes firm fixed pricing and was awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits, with a contract ceiling value of $7,809.84. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed-price pricing under a non-competitive set-aside arrangement. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1 mg glucagon emergency kits valued at $1,398.44. The contract, awarded on August 7, 2025, carries a firm fixed price structure and is scheduled for completion by August 8, 2025. This is an unset-aside, competitively awarded delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The glucagon kits will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,368.20 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Glucagon 1 mg Emergency Kits. This firm fixed-price contract, issued without set-aside designation, is scheduled for completion by August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,557.64 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits. The contract, executed on July 22, 2025, with an ultimate completion date of July 23, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting military...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Glucagon 1 mg Emergency Kits with a ceiling value of $1,055.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for ultimate completion on August 1, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2QSDelivery Order
The Defense Logistics Agency awarded a $1,385.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg Emergency Kits under contract number 4568832315. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 21, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a child contract under the Pharmaceutical Prime Vendor Global Program, this delivery order reflects the company's established capability to supply specialized medical products and pharmaceutical commodities to support Department of Defense healthcare requirements. The contract demonstrates the company's role in providing emergency medical supplies and medications across the federal healthcare supply chain, with pricing structured on a firm fixed price basis typical of DLA medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/18/25 |